Search Results - Adam P. Sima
- Showing 1 - 9 results of 9
-
1
-
2
Incorporating professional recommendations into a graduate-level statistical consulting laboratory: A case study by Adam P. Sima, Viviana A. Rodriguez, Keighly E. Bradbrook, Brian S. DiPace, Victoria Okhomina
Published in Journal of Clinical and Translational Science (2021-01-01)Get full text
Article -
3
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry by Philip J. Mease, Andrew Blauvelt, Adam P. Sima, Silky W. Beaty, Robert Low, Braulio Gomez, Marie Gurrola, Mark G. Lebwohl
Published in Dermatology and Therapy (2024-09-01)Get full text
Article -
4
Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International... by Bruce Strober, Manish Patel, Mark I. Kaldas, Greg St. John, Huzefa Photowala, Adam P. Sima, Thomas Eckmann, Alicia Beeghly, April Armstrong
Published in Dermatology and Therapy (2025-07-01)Get full text
Article -
5
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry by Andrew Blauvelt, Robert R. McLean, Silky W. Beaty, Adam P. Sima, Robert Low, Jeffrey L. Stark, Laura McClung, Jerry Bagel
Published in Dermatology and Therapy (2024-09-01)Get full text
Article -
6
Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry by Robert R. McLean, Adam P. Sima, Silky Beaty, Robert Low, Rebecca L. Spitzer, Jeffrey L. Stark, Elizabeth Lesser, Edward Lee, April Armstrong
Published in Dermatology and Therapy (2023-09-01)Get full text
Article -
7
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry by Robert R. McLean, Adam P. Sima, Silky Beaty, Eric A. Jones, Thomas Eckmann, Robert Low, Laura McClung, Rebecca L. Spitzer, Jeffrey Stark, April Armstrong
Published in Dermatology and Therapy (2023-09-01)Get full text
Article -
8
Effects of two different paradigms of electrical stimulation exercise on cardio-metabolic risk factors after spinal cord injury. A randomized clinical trial by Ashraf S. Gorgey, Ashraf S. Gorgey, Refka E. Khalil, William Carter, Boyd Ballance, Ranjodh Gill, Ranjodh Gill, Rehan Khan, Lance Goetz, Lance Goetz, Timothy Lavis, Timothy Lavis, Adam P. Sima, Robert A. Adler, Robert A. Adler
Published in Frontiers in Neurology (2023-09-01)Get full text
Article -
9
Skeletal muscle hypertrophy and attenuation of cardio-metabolic risk factors (SHARC) using functional electrical stimulation-lower extremity cycling in persons with spinal cord inj... by Ashraf S. Gorgey, Refka E. Khalil, John C. Davis, William Carter, Ranjodh Gill, Jeannie Rivers, Rehan Khan, Lance L. Goetz, Teodoro Castillo, Timothy Lavis, Adam P. Sima, Edward J. Lesnefsky, Christopher C. Cardozo, Robert A. Adler
Published in Trials (2019-08-01)Get full text
Article
